Research groups
| Molecular Biology of Breast Cancer | Cancer genome variation |
|
|
|
| Headed by Group Leader and Professor Anne-Lise Børresen-Dale |
Headed by Group Leader and Professor Vessela N. Kristensen |
Project groups
Our goal is to follow the linear time course of predisposition, initiation, early stages and advanced disease and to dissect the molecular mechanisms triggered at each stage and to follow the multidimentional interactions at various levels in a systems biology approach to be able to better do risk estimation, prognostication and prediction.
To reach these goals we have divided our research into 7 activities:
- Gene environment interaction in breast cancer risk
- Tumor initiation and early diagnosis
- Tumor progression and metastasis
- Prediction of treatment response and targeted therapy
- Integrated approaches
- Functional validation
- Biostatistical challenges and approaches
![]() | Anne-Lise Børresen-Dale is chair of the 21st biennial Meeting of the EACR, which is held Oslo, Norway, 26-29 June, 2010. Conference web page - click here. |
Contact information:
Department of Genetics, Institute for Cancer Research
The Norwegian Radium Hospital, N-0310 Oslo, Norway
Phone: +47 22 93 56 77, Fax: +47 22 93 44 40, Switchboard: +47 22 93 40 00
Research coordinator: Gry A. Geitvik
Department secretary: Mona Hagen
Mar 8, 2010
21st Meeting of the European Association for Cancer Research, 26 - 29 June 2010
Feb 25, 2010
Latest publications
Department of Genetics
SNPs in genes coding for ROS metabolism and signalling in association with docetaxel clearance
Pharmacogenomics J (in press)
PubMed 20157331
Epithelial-Stromal Interaction 1 (EPSTI1) Substitutes for Peritumoral Fibroblasts in the Tumor Microenvironment
Am J Pathol (in press)
PubMed 20133812
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study
Hum Mutat, 31 (3), E1200-40
PubMed 20104584











Print this page
